Company

Samyang Biopharm USA, Inc.Samyang Biopharm USA, Inc.

Future growth strategy revolves in the field of biologics at our first affiliate office in Cambridge, Massachusetts

Located in One Kendall Square Located in One Kendall Square

Samyang Biopharm USA IncSamyang Biopharm USA Inc

Samyang Biopharm USA was established in October 2018 with the goal of conducting R&D activities with an emphasis on the field of immuno-oncology and rare disease drugs. We collaborate with various competitive companies, start-ups, research institutes, hospitals, and universities in the pharmaceutical industry through “Open Innovation” strategy.

Oncology
Rare Disease
Antibodies
Antibody Drug Conjugate, ADC
Recombinant Proteins
Late Preclinical to
Phase1
We look forward to a successful partnership with a company that has unique technology and products applicable to the anticancer fields such as immuno-oncology. We look forward to a successful partnership with a company that has unique technology and products applicable to the anticancer fields such as immuno-oncology.
Contact us
If you need further information on open innovation, please get in touch with us.

inquiry